查詢結果分析
相關文獻
頁籤選單縮合
題名 | Potential Therapeutic Agents against COVID-19: What We Know So Far= |
---|---|
作者 | Lu, Chih-chia; Chen, Mei-yu; Lee, Wan-shin; Chang, Yuh-lih; |
期刊 | Journal of the Chinese Medical Association |
出版日期 | 20200600 |
卷期 | 83:6 2020.06[民109.06] |
頁次 | 頁534-536 |
分類號 | 415.239 |
語文 | eng |
關鍵詞 | Chloroquine; COVID-19; Favipiravir; Hydroxychloroquine; Interferon; Lopinavir/ritonavir; Remdesivir; Ribavirin; Sarilumab; Severe acute respiratory syndrome coronavirus 2; Tocilizumab; |
英文摘要 | The emerging outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 continues to spread all over the world. Agents or vaccines of proven efficacy to treat or prevent human coronavirus infection are in urgent need and are being investigated vigorously worldwide. This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavirin, tocilizumab, and sarilumab. More clinical trials are being conducted for further confirmation of the efficacy and safety of these agents in treating COVID-19. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。